Ovarian_cancer_screening:_potential_effect_on_mortality._Serum_tumor_markers_and_ultrasonography_are_being_investigated_as_possible_ovarian_cancer_screening_tests._Data_from_the_United_States_on_ovarian_cancer_incidence_and_survival_were_used_to_estimate_the_potential_benefit_on_ovarian_cancer_mortality_from_screening_tests_of_various_sensitivities._A_test_with_80%_sensitivity_could_reduce_ovarian_cancer_mortality_by_50%_if_all_screening-detected_cases_were_to_experience_current_stage_I_survival_rates;_the_benefit_would_be_greatest_among_women_aged_45_or_older._For_each_cancer_detected_there_would_be_at_least_50_false-positive_screening_tests_unless_test_specificity_is_greater_than_98%._If_our_most_optimistic_assumptions_about_screening_could_be_met,_then_universal_periodic_screening_of_women_aged_45_to_74_would_result_in_about_5000_additional_5-year_survivors_of_ovarian_cancer_annually._Uptake_of_existing_screening_tests_is_far_less_than_universal;_thus_we_would_expect_the_impact_of_any_ovarian_cancer_screening_program_to_fall_short_of_these_projections.